Clairity Breast AI tool is rolling out nationwide to predict five-year breast cancer risk

The New York Times describes Clairity Breast as an AI tool that can predict five-year breast cancer risk and is rolling out nationwide. Eric Topol says it can identify high risk even when a mammogram is read as “normal.” He says the tool has FDA approval and argues it should be free and included in every mammogram readout.